| Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979) |
|---|
| 02/21/2002 | DE10039998A1 Neue substituierte Diareno-azepin-Derivate als Integrin Liganden New substituted Diareno-azepine derivatives as integrin ligands |
| 02/21/2002 | CA2419181A1 Processes for preparing cilostazol |
| 02/21/2002 | CA2418853A1 2,4-substituted pyridine derivatives |
| 02/21/2002 | CA2418389A1 Pyridine derivatives as inhibitors of p38 |
| 02/21/2002 | CA2417846A1 2-aminopyridine compounds and medical use thereof |
| 02/20/2002 | EP1180513A1 Cyclic amide compounds, process for the preparation of the same and uses thereof |
| 02/20/2002 | EP1180366A1 Neuronal death inhibitors |
| 02/20/2002 | EP1180103A1 Renin inhibitors |
| 02/20/2002 | EP1180102A1 Mutual prodrugs of amlodipine and atorvastatin |
| 02/20/2002 | EP1180101A1 Compounds having cytokine inhibitory activity |
| 02/20/2002 | EP0927171B1 Pyrazinones and triazinones and their derivatives thereof |
| 02/20/2002 | EP0841922B1 1h-4(5)-substituted imidazole derivatives |
| 02/20/2002 | CN1336930A Bridged heterocyclic derivatives |
| 02/20/2002 | CN1336927A Cyclic guanidine derivatives and their use as pesticides |
| 02/20/2002 | CN1336925A 4,5,6 and 7-indole and indoline derivatives, their prepn. and use |
| 02/20/2002 | CN1336924A Amide and urea derivatives as 5-HT reuptake inhibitors and at 5-HT 1B/1D ligands |
| 02/20/2002 | CN1336919A Phenylphenanthridines with PDE-IV inhibiting activity |
| 02/20/2002 | CN1336917A Amide compounds |
| 02/20/2002 | CN1336916A Arylpiperazinyl-cyclohexyl indole derivatives for the treatment of depression |
| 02/20/2002 | CN1336915A Urea of N-heterocyclic carboxylic acid or the isostere of carboxylic acid and aminocarboxylic acid ester |
| 02/20/2002 | CN1079397C 4-(benzo-1,3-dioxolyl)-pyrrolidine-3-carboxylic acid derivatives as endothelin antagonists |
| 02/20/2002 | CN1079396C Aromatic amidine derivatives useful as selective thrombin inhibitors |
| 02/19/2002 | US6348627 Aryl and heteroarylcyclopropyl oxime ethers and their use as fungicides |
| 02/19/2002 | US6348597 Intermediate p-cyclopropanoyl cumene compounds and derivatives, optionally having a 3-hydroxy group; 1-(benzoylalkyl)-4-(diphenylmethoxy)-piperidine compounds and 1-(a-hydroxybenzylalkyl)-4-(diphenylalkenyl)-piperidines |
| 02/19/2002 | US6348482 Catechols as antimicrobial agents |
| 02/19/2002 | US6348480 Pharmaceutical compound comprising a pyrazole derivative and methods of using the same for the treatment of calcium release-activated calcium channel associated diseases |
| 02/19/2002 | US6348468 Pyridazine compounds and compositions containing the same |
| 02/19/2002 | US6348463 Phenylalanine derivatives |
| 02/19/2002 | US6348461 Central nervous system antagonist with heterocyclic substituents |
| 02/19/2002 | US6348032 Method of inhibiting neoplastic cells with benzimidazole derivatives |
| 02/19/2002 | CA2082568C Amorphous (quinolin-2-ylmethoxy) indoles |
| 02/14/2002 | WO2002070513A1 Methods for the preparation of mirtazapine intermediates |
| 02/14/2002 | WO2002012399A1 Organic compounds |
| 02/14/2002 | WO2002012235A1 1,4-dihydropyridines as bradykinin antagonists |
| 02/14/2002 | WO2002012232A1 Tartrate salt of thiazolidinedione derivative |
| 02/14/2002 | WO2002012228A1 Cinnoline compounds |
| 02/14/2002 | WO2002012227A2 Indole, azaindole and indazole derivatives having vegf inhibiting activity |
| 02/14/2002 | WO2002012226A1 Quinoline derivatives having vegf inhibiting activity |
| 02/14/2002 | WO2002012225A1 Salts of benzimidazole compound and use thereof |
| 02/14/2002 | WO2002012224A2 Bicyclic compounds as h3 receptor ligands |
| 02/14/2002 | WO2002012214A2 Non-imidazole aryloxyalkylamines as h3 receptor ligands |
| 02/14/2002 | WO2002012199A1 Heterocyclic mutilin esters and their use as antibacterials |
| 02/14/2002 | WO2002012198A2 4-pyrimidinamine derivatives, pharmaceutical compositions and related methods |
| 02/14/2002 | WO2002012196A2 Lactam compounds and their use as inhibitors of serine proteases and method |
| 02/14/2002 | WO2002012193A1 Tetrahydroisoquinoline-3-carboxylic acid alkoxyguanidines as integrin antagonists |
| 02/14/2002 | WO2002012191A1 Cyclic amine derivatives and use thereof |
| 02/14/2002 | WO2002012190A2 Non-imidazole aryloxypiperidines as h3 receptor ligands |
| 02/14/2002 | WO2002012187A1 Novel phenylheteroazetidines, useful as nitric oxide synthase inhibitors |
| 02/14/2002 | WO2002012178A1 Compounds acting as melanocortin receptor ligands |
| 02/14/2002 | WO2002012166A2 Triamine derivative melanocortin receptor ligands and methods of using same |
| 02/14/2002 | WO2002011766A2 Use of 5ht4 receptor antagonists in the manufacture of a medicament for the prophylaxis or treatment of atrial fibrillation |
| 02/14/2002 | WO2002011726A1 Highly absorbable solid preparation |
| 02/14/2002 | WO2002011724A2 Neuroprotective 2-pyridinamine compositions and related methods |
| 02/14/2002 | WO2002005616A8 Novel 6-phenylphenanthridines |
| 02/14/2002 | WO2001070671A3 Insecticidal anthranilamides |
| 02/14/2002 | WO2001068603A3 Cyclopropyl-fused pyrrolidine-based inhibitors of dipeptidyl iv, processes for their preparation, and their use |
| 02/14/2002 | WO2001057021A3 2-[1H]-QUINOLONE AND 2-[1H]-QUINOXALONE INHIBITORS OF FACTOR Xa |
| 02/14/2002 | WO2001055119A3 Gonadotropin-releasing hormone receptor antagonists and methods relating thereto |
| 02/14/2002 | WO2001051479A3 Tricyclic compounds with antiviral activity |
| 02/14/2002 | WO2001049668A3 4-aryl-1-difluoromethoxyimidazoles and use thereof as herbicides |
| 02/14/2002 | US20020019534 Gem substituted hydroxamic acids |
| 02/14/2002 | US20020019533 Piperidine derivatives and anti-platelet agents containing the same |
| 02/14/2002 | US20020019531 Indoles |
| 02/14/2002 | US20020019530 Antitumor agent |
| 02/14/2002 | US20020019527 Antitumor, antcarcinogenic agents |
| 02/14/2002 | US20020019525 Pyrido [2,3-b] indolizine derivatives and aza analogues thereof; CRF1 specific ligands |
| 02/14/2002 | US20020019523 Dietetics; antidabetic agents; sexual disrders |
| 02/14/2002 | US20020019436 Central nervous system disorders |
| 02/14/2002 | US20020019429 Antiarthritic agents; osteoporosis |
| 02/14/2002 | US20020019424 1-sulfonyl pyrrolidine derivatives |
| 02/14/2002 | US20020019420 Antiulcer agents; side effect reduction |
| 02/14/2002 | US20020019416 Esters and amides as pla2 inhibitors |
| 02/14/2002 | US20020019414 N-aryl(thio)anthranilic acid amide derivatives, their preparation and their use as VEGF receptor tyrosine kinase inhibitors |
| 02/14/2002 | US20020019411 Cyclopropyl-fused pyrrolidine-based inhibitors of dipeptidyl peptidase IV and method |
| 02/14/2002 | US20020019408 New isoxazole-sulfonamide endothelin antagonists |
| 02/14/2002 | US20020019405 Nitrosated and nitrosylated phosphodiesterase inhibitors, compositions and methods of use |
| 02/14/2002 | US20020019402 Integrin inhibitors and their methods of use |
| 02/14/2002 | US20020019400 Compounds useful for inhibition of farnesyl protein transferase |
| 02/14/2002 | US20020019395 Indalone and benzimidazolone inhibitors of factor Xa |
| 02/14/2002 | US20020019393 Treating inflammation, autoimmune diseases, destructive bone disorders, proliferative disorders, infections, neurvous system disorders, reperfusion/ischemia in stroke, cardiovascular disorders, hypoxia, edema, fever, pain |
| 02/14/2002 | US20020019390 Imidazole and imidazoline derivatives and uses thereof |
| 02/14/2002 | US20020019389 3-(N-(5,6-dimethyl-2-methoxypyridin-3-yl)aminocarbonyl)-7,8-dimethoxy-1-phenyl-2,3,4,5-tetrahydro-3H-benzazepine, for example |
| 02/14/2002 | US20020019387 2-((2,3,4-trifluorophenyl)methyl),4-(carboxymethyl), 8-(pyrid-2-yl-aminopropoxy)-2,3,4,5-1H-2-benazepin-3-one and N-oxides thereof; with antineoplastics inhibiting tumor growth, treating atherosclerosis, restenosis, osteoporosis |
| 02/14/2002 | US20020019386 5-HT4 receptor antagonists |
| 02/14/2002 | US20020019384 4-(3-((((3-(4-((3-Methylbutyl)amino)-1-piperidinyl)propyl) -amino)-carbonyl)amino)phenyl)-1,4-dihydro-2,6-dimethyl-3,5 -pyridinedicarboxylic acid, dimethyl ester dihydrochloride, for example; anorexiant; Neuropeptide Y (NPY) |
| 02/14/2002 | US20020019383 3-amido or 3-sulfonylamino azetidine compounds and their preparation; high affinity for cannabinoid receptor CB1 type, useful in treating central nervous system, immune, gastrointestinal or cardiovascular disorders, drug abuse |
| 02/14/2002 | US20020019382 Curcumin analogs with anti-tumor and anti-angiogenic properties |
| 02/14/2002 | US20020019371 Use as anticoagulants; competitive inhibitors of thrombin; for example, 1-(phenyl-2-hydroxyethane-1,1-diylcarbonyl), 2-((4-amidinophenyl)- alkylaminocarbonyl)azetidine |
| 02/14/2002 | CA2775616A1 Salts of benzimidazole compound and application thereof |
| 02/14/2002 | CA2438446A1 Methods for the preparation of mirtazapine intermediates |
| 02/14/2002 | CA2419036A1 Non-imidazole aryloxypiperidines as h3 receptor ligands |
| 02/14/2002 | CA2419030A1 4-pyrimidinamine derivatives, pharmaceutical compositions and related methods |
| 02/14/2002 | CA2419027A1 Bicyclic compounds as h3 receptor ligands |
| 02/14/2002 | CA2418995A1 Lactam compounds and their use as inhibitors of serine proteases and method |
| 02/14/2002 | CA2418912A1 Neuroprotective 2-pyridinamine compositions and related methods |
| 02/14/2002 | CA2418904A1 Use of 5ht4 receptor antagonists in the manufacture of a medicament for the prophylaxis or treatment of atrial fibrillation |
| 02/14/2002 | CA2418369A1 Non-imidazole aryloxyalkylamines as h3 receptor ligands |
| 02/14/2002 | CA2417827A1 Tartrate salt of thiazolidinedione derivative |
| 02/14/2002 | CA2416525A1 Indole, azaindole and indazole derivatives having vegf inhibiting activity |
| 02/14/2002 | CA2415469A1 Quinoline derivatives having vegf inhibiting activity |